Cytonus Therapeutics Expands C-suite as it Transitions to a Clinical Stage Company [Yahoo! Finance]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Yahoo! Finance
generation drug-delivery platform technology called Cargocytes™, announced today that Mickey Kim, M.D., M.B.A. has joined the company as Chief Business Officer. In addition, Cytonus has added Sherry M. Carty, Ph.D., as Director of Intellectual Property and Karen Markham has been promoted to Chief Administrative Officer. Dr. Kim brings significant corporate development, strategy, innovation and management experience. Dr. Kim was the Senior Vice President of Corporate Development and Head of Global Products at CareDx, Inc., where he led mergers and acquisitions, business development and collaboration activities. He also was the general manager of the company's global kitted diagnostic business with offices in Australia, Sweden and the U.S. "I'm very excited to add Dr. Kim to our management team as we grow Cytonus and establish the Cargocyte as a best-in-class drug delivery platform," said Cytonus' Chief Executive Officer and cofounder, Remo Moomiaie-Qajar, M.D. "His expertise, ins
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock.MarketBeat
- CareDx to Report First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- CareDx to Report First Quarter 2024 Financial ResultsBusiness Wire
CDNA
Earnings
- 2/28/24 - Beat
CDNA
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 3
- 5/3/24 - Form 4
- CDNA's page on the SEC website